The goal of our Report was to test the hypothesis that mammalian motile cilia could act as a chemosensory organelle, and we used the bitter signal transduction system as a test ("Motile cilia of human airway epithelia are chemosensory," 28 August 2009, p. 1131, published online 23 July 2009). A. Pronin indicates that correlations between T2R alleles and individuals' sensitivity to bitter tastants has been the most compelling evidence that T2R receptors detect bitter compounds and mediate the sense of taste. He goes on to say that we should do the corresponding study in airway epithelia. We agree that his work (1) and that of others (2–4) correlating T2R alleles and bitter taste sensitivity has been important. But many other discoveries indicated that T2Rs are receptors for bitter compounds [for examples see (5–10)], and a narrow focus on correlating T2R alleles and bitter taste sensitivity misses the contribution of that work, as well as important points in our Report. Although the experiment that Pronin proposes could be interesting, our current data support the conclusions of our Report.
In our Report, multiple experiments revealed that T2Rs and their signal transduction machinery are located in ciliated epithelial cells and that bitter compounds elicit a cellular response. Pronin emphasizes denatonium. However, we also discovered that [Ca2+]i increased in response to salicin (100 micromolar/200 micromolar/70 micromolar), thujone (10 micromolar/-/3–30 micromolar), quinine (100 micromolar/1 micromolar/300 micromolar), and nicotine (100 micromolar/19 micromolar/100 micromolar) (parentheses indicate: concentration we tested/taste sensitivity in vivo/concentrations raising [Ca2+]i in our in vitro assays) (4, 9, 11–13). We applied denatonium at 100 micromolar, which is greater than the concentration detectable by humans. Although Pronin says that mM denatonium can cause artifacts, studies indicating that mM concentrations of denatonium stimulated hT2R4 and mT2R8 contained controls indicating that the response was not an artifact (6). Moreover, we found that denatonium only increased [Ca2+]i in epithelial cells that were ciliated (fig. S8 of our Report).
More important, there need not be a close correlation between a psychophysical gustatory response in humans and a physiologic response in airway epithelia. The relationship between concentration and response could differ substantially for the perceived taste of a compound and for its stimulation of airway epithelial cells. Our findings that various T2Rs show distinct localization patterns along the cilia also raise the possibility that different T2Rs may vary in their coupling to signaling pathways. Thus, Pronin's comments about denatonium concentration might not hold for physiological or biochemical studies in lung cells. Indeed, using a biochemical assay, Pronin previously reported that 10 to 30 micromolar denatonium was required to activate T2R44 (14) and said, "Although the concentration of denatonium needed for detectable activation of hT2R44 in the GTPγS binding assay is still significantly higher than the reported 'bitter threshold' in humans, we do not expect it to match precisely human taste sensitivity. The 'bitter threshold' is a concentration at which humans begin to differentiate between water alone and water plus a compound (i.e., 'barely detectable'). Sensory detection thresholds are often much lower than observed in heterologous assays."
Pronin says that we should determine whether variations in individuals' sensitivity to tasting phenylthiocarbamide (PTC) correlate with the response of ciliated airway epithelia to PTC. We have not tested PTC on airway epithelia. Although we agree that this could be an interesting study, testing for such a correlation would be technically difficult. We used primary cultures of differentiated human airway epithelial cells derived from trachea and bronchi obtained from lungs rejected for organ transplant. Obtaining cultures from individuals who were screened for PTC sensitivity would not be a trivial undertaking. In addition, interpretations can be complicated because most bitter compounds activate multiple T2Rs (4, 6, 9, 12, 15).
We thank Dr. Pronin for the suggestion.
Michael J. Welsh, Alok S. Shah, and Yehuda Ben-Shahar
Department of Internal Medicine, Howard Hughes Medical Institute, University of Iowa, Iowa City, IA 52242, USA.
References
1. A. N. Pronin et al., Curr. Biol. 17, 1403 (2007).
2. U. K. Kim et al., Science 299,1221 (2003).
3. B. Bufe et al., Curr. Biol. 15, 322 (2005).
4. B. Bufe, T. Hofmann, D. Krautwurst, J. D. Raguse, W. Meyerhof, Nat. Genet. 32, 397 (2002).
5. E. Adler et al., Cell 100, 693 (2000).
6. J. Chandrashekar et al., Cell 100, 703 (2000).
7. H. Matsunami, J. P. Montmayeur, L. B. Buck, Nature 404, 601 (2000).
8. J. Chandrashekar, M. A. Hoon, N. J. Ryba, C. S. Zuker, Nature 444, 288 (2006).
9. W. Meyerhof, Rev. Physiol. Biochem. Pharmacol. 154, 37 (2005).
10. K. L. Mueller et al., Nature 434, 225 (2005).
11. M. Behrens et al., Biochem. Biophys. Res. Commun. 319, 479 (2004).
12. A. Caicedo, E. Pereira, R. F. Margolskee, S. D. Roper, J. Neurosci. 23, 9947 (2003).
13. L. Liu, S. A. Simon, Chem. Senses 23, 125 (1998).
14. A. N. Pronin, H. Tang, J. Connor, W. Keung, Chem. Senses 29, 583 (2004).
15. M. Behrens, C. Reichling, C. Batram, A. Brockhoff, W. Meyerhof, Ann. N. Y. Acad. Sci. 1170, 111 (2009).